Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contraction of hepatic stellate cells (HSCs) plays an important role in the pathogenesis of liver fibrosis by regulating sinusoidal blood flow and extracellular matrix remodeling. Here, we investigated how HSC contraction was affected by the natural compound oroxylin A, and elucidated the underlying mechanism. METHODS: Cell contraction and glycolysis were examined in cultured human HSCs and mouse liver fibrosis model upon oroxylin A intervention using diversified cellular and molecular assays, as well as genetic approaches. RESULTS: Oroxylin A limited HSC contraction associated with inhibiting myosin light chain 2 phosphorylation. Oroxylin A blocked aerobic glycolysis in HSCs evidenced by reduction in glucose uptake and consumption and lactate production. Oroxylin A also decreased extracellular acidification rate and inhibited the expression and activity of glycolysis rate-limiting enzymes (hexose kinase 2, phosphofructokinase 1 and pyruvate kinas type M2) in HSCs. Then, we identified that oroxylin A blockade of aerobic glycolysis contributed to inhibition of HSC contraction. Furthermore, oroxylin A inhibited the expression and activity of lactate dehydrogenase-A (LDH-A) in HSCs, which was required for oroxylin A blockade of glycolysis and suppression of contraction. Oral administration of oroxylin A at 40 mg/kg reduced liver injury and fibrosis, and inhibited HSC glycolysis and contraction in mice with carbon tetrachloride-induced hepatic fibrosis. However, adenovirus-mediated overexpression of LDH-A significantly counteracted the oroxylin A's effects in fibrotic mice. CONCLUSIONS: Blockade of aerobic glycolysis by oroxylin A via inhibition of LDH-A reduced HSC contraction and attenuated liver fibrosis, suggesting LDH-A as a promising target for intervention of hepatic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Current paradigm has established that hepatic stellate cells (HSCs) are key effector cells in the initiation and development of hepatic fibrosis [1].”
BackgroundThe origin of fibrogenic myofibroblasts in fibrotic liver
Kisseleva, T. (2017) · Hepatology · doi:10.1002/hep.28948 · Cited by 224
Lian, N., Jiang, Y., Zhang, F., Jin, H., Lu, C., Wu, X., Lu, Y., & Zheng, S. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.59 · Cited by 64
Self-citation
Cited by
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Rho, H., Terry, A. R., Chronis, C., & Hay, N. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.013 · Cited by 404
Shen, M., Li, Y., Wang, Y., Shao, J., Zhang, F., Yin, G., Chen, A., Zhang, Z., & Zheng, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102151 · Cited by 231
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationZhou, Y., Yan, J., Huang, H., Liu, L., Ren, L., Hu, J., Jiang, X., Zheng, Y., Xu, L., Zhong, F., et al. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06509-9 · Cited by 92
“A growing body of evidence suggests that HSCs employ aerobic glycolysis during activation, and inhibiting this process effectively halts HSCs activation [6 – 8].”
BackgroundMetabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology
Chang, M.-L., & Yang, S.-S. (2019) · Cells · doi:10.3390/cells8111423 · Cited by 81
“Emerging evidence suggests that HSCs utilize aerobic glycolysis during activation [22], and the inhibition of aerobic glycolysis blocks HSC contraction [23].”
Background
Metadata
- Authors
- Wang, F., Jia, Y., Li, M., Wang, L., Shao, J., Guo, Q., Tan, S., Ding, H., Chen, A., Zhang, F., & Zheng, S.
- Venue
- Cell Communication and Signaling
- Published
- 2019-02-11
- Volume
- 17
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1478-811X (ISSN-L)
- OpenAlex
- W2918512435
- Cited by
- 55
- References
- 3
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells. https://app.cochat.ai/papers/10.1186/s12964-019-0324-8
- The paper
- Wang, F., Jia, Y., Li, M., Wang, L., Shao, J., Guo, Q., Tan, S., Ding, H., Chen, A., Zhang, F., & Zheng, S. (2019). Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells. Cell Communication and Signaling. https://doi.org/10.1186/s12964-019-0324-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.